The Economics of Essential Medicines

Front Cover
Brigitte Granville
Royal Institute of International Affairs, 2002 - Business & Economics - 300 pages
0 Reviews

This volume highlights the pressing issue of the availability of essential medicines in developing countries. It includes perspectives from developed and developing countries, the public and the private sector, and health service delivery, as well as research and development issues.Contributors include Keith Maskus (University of Colorado), Jayashree Watal (Intellectual Property Division, WTO), Owen Lippert (Fraser Institute, Canada Oxfam Paper), Harvey Bale (International Federation of Pharmaceutical Manufacturers Association), Jorge A.Z. Bermudez (National School of Public Health, Oswaldo Cruz Foundation, Brazilian Ministry of Health), Dorothy Ochola (UNAIDS/Ministry of Health HIV/AIDS Drug Access Initiative, Uganda), Jillian Cohen, World Bank-PAHO Pharmaceuticals Liaison Officer), Duncan Reekie (University of the Witwatersrand, South Africa), Jeffrey L. Sturchio (Merck & Company), Markus Haacker (IMF), Andrew Creese (World Health Organization), and Louisiana Lush (London School of Hygiene and Tropical Medicine).

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

A Market Perspective on Recent Developments in the TRIPS
3
The Economics of TRIPS Options for Access to Medicines
32
Implications for
57
Copyright

14 other sections not shown

Common terms and phrases

About the author (2002)

Brigitte Granville is a professor of international economics and economic policy at the Centre for Business Management, Queen Mary, University of London and former head of the International Economics Programme at RIIA.

Bibliographic information